InCarda Therapeutics incardatherapeutics.com

InCarda Therapeutics is a privately-held, clinical-stage biopharmaceutical company developing an approach of treating cardiovascular conditions by the inhalation route. The advantage of inhalation is that it delivers medicine in the “first pass” to cardiac tissue, presenting a small, but effective dose of drug directly to affected regions of the heart. This permits rapid-onset, lower off-target tissue exposure of the drug, lower continued/prolonged exposure to cardiac tissue and, more import...Show all

InCarda Therapeutics is a privately-held, clinical-stage biopharmaceutical company developing an approach of treating cardiovascular conditions by the inhalation route. The advantage of inhalation is that it delivers medicine in the “first pass” ...Show all

Company (Alive / Active)

All investors data 8 Investors

• 5Y Capital
• Deerfield Management
• HealthCap Venture Capital
• Innoviva
• Morningside Group (晨兴集团)

Board Members

Patents